Saturday, 30 March 2024
Catabasis Pharmaceuticals Inc
19:45 | 1/3/18
Frisco Fastball
Analysts expect Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) to report $-0.31 EPS on March, 15.They anticipate $0.16 EPS change or 34.04 % from last quarter's $-0.47 EPS.
more»
23:18 | 28/2/18
Wall Street Morning
On Tuesday, Catabasis Pharmaceuticals, Inc. (CATB) made the way into the market negative movers list with falling -2.86%.
more»
05:41 | 28/2/18
Post Analyst
Catabasis Pharmaceuticals, Inc. is maintained at an average buy rating by 3 stock analysts, and there are at least 0.25% of shares outstanding that are currently legally short sold.
more»
20:18 | 27/2/18
Frisco Fastball
Analysts expect Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) to report $-0.31 EPS on March, 15.They anticipate $0.16 EPS change or 34.04 % from last quarter's $-0.47 EPS.
more»
This is a real time view of the critical technical pivot points for Catabasis Pharmaceuticals Inc (NASDAQ:CATB) . The technical pivot points we look at all surround the stock price movement from the last 10-trading days through the last year.
more»
03:15 | 24/2/18
StockNewsGazette
The shares of Catabasis Pharmaceuticals, Inc. have increased by more than 12.42% this year alone. The shares recently went up by 8.77% or $0.13 and now trades at $1.67.
more»
02:41 | 21/2/18
Alpha Beta Stock
Global bonds fell, with shareholders driving the benchmark Treasury yield up to the highest levels in four years, as the dollar advanced as compared to its major peers and West Texas oil climbed.
more»
Price Alert: Catabasis Pharmaceuticals Inc (NASDAQ:CATB) has now crossed into technical strength -- watch the technical oscillators for momentum gaps.
more»
01:56 | 14/2/18
Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today reported new positive efficacy and safety results showing preservation of muscle function and sustained disease ...
more»
03:26 | 9/2/18
Stock Talker
Watching some historical volatility numbers on shares of Catabasis Pharmaceuticals, Inc. (NasdaqGM:CATB), we can see that the 12 month volatility is presently 143.082700.
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |